These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 24055805)

  • 1. Vasonatrin peptide, a novel protector of dopaminergic neurons against the injuries induced by n-methyl-4-phenylpyridiniums.
    Zhao HK; Chen BY; Chang R; Wang JB; Ni F; Yang L; Dong XC; Sun SH; Zhao G; Fang W; Ma QR; Wang XL; Yu J
    Peptides; 2013 Nov; 49():117-22. PubMed ID: 24055805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protecting effects of vasonatrin peptide against carbon tetrachloride-induced liver fibrosis.
    Chen BY; Qu P; Tie R; Zhu MZ; Zhu XX; Yu J
    Regul Pept; 2010 Sep; 164(2-3):139-43. PubMed ID: 20619296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasonatrin peptide, a new regulator of adiponectin and interleukin-6 production in adipocytes.
    Chen BY; Tie R; Qu P; Zhu MZ; Zhu XX; Jin J; Yu J
    J Endocrinol Invest; 2011 Nov; 34(10):742-6. PubMed ID: 21625198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of C-type natriuretic peptide receptor by vasonatrin peptide in cardiac myocytes and fibroblasts.
    Lü SY; Zhu MZ; Wang DS; Yu J; Guo HT; Hu YZ; Wei QM
    Acta Pharmacol Sin; 2004 Apr; 25(4):424-30. PubMed ID: 15066207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenylpyridium ion (MPP+) enhances glutamate-induced cytotoxicity against dopaminergic neurons in cultured rat mesencephalon.
    Sawada H; Shimohama S; Tamura Y; Kawamura T; Akaike A; Kimura J
    J Neurosci Res; 1996 Jan; 43(1):55-62. PubMed ID: 8838574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway.
    Zhai A; Zhu X; Wang X; Chen R; Wang H
    Eur J Pharmacol; 2013 Aug; 713(1-3):58-67. PubMed ID: 23665112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hypoxia-induced proliferation and collagen synthesis by vasonatrin peptide in cultured rat pulmonary artery smooth muscle cells.
    Lu SY; Wang DS; Zhu MZ; Zhang QH; Hu YZ; Pei JM
    Life Sci; 2005 May; 77(1):28-38. PubMed ID: 15848216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF.
    Jakobsen B; Gramsbergen JB; Møller Dall A; Rosenblad C; Zimmer J
    Eur J Neurosci; 2005 Jun; 21(11):2939-48. PubMed ID: 15978005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic neurotoxicity by 6-OHDA and MPP+: differential requirement for neuronal cyclooxygenase activity.
    Carrasco E; Casper D; Werner P
    J Neurosci Res; 2005 Jul; 81(1):121-31. PubMed ID: 15931668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the time courses of selective gene expression and dopaminergic depletion induced by MPP+ in MN9D cells.
    Wang J; Duhart HM; Xu Z; Patterson TA; Newport GD; Ali SF
    Neurochem Int; 2008 May; 52(6):1037-43. PubMed ID: 18069091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K(ATP) channel openers protect mesencephalic neurons against MPP+-induced cytotoxicity via inhibition of ROS production.
    Xie J; Duan L; Qian X; Huang X; Ding J; Hu G
    J Neurosci Res; 2010 Feb; 88(2):428-37. PubMed ID: 19746425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fucoidan protects against dopaminergic neuron death in vivo and in vitro.
    Luo D; Zhang Q; Wang H; Cui Y; Sun Z; Yang J; Zheng Y; Jia J; Yu F; Wang X; Wang X
    Eur J Pharmacol; 2009 Sep; 617(1-3):33-40. PubMed ID: 19545563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vasonatrin peptide attenuates the enhancement of electrically-induced intracellular calcium transient by isoproterenol in rat cardiac myocytes].
    Guo HT; Zhu MZ; Zhang RH; Bi H; Zhang B; Zhang HF; Yu J; Lu SY; Pei JM
    Sheng Li Xue Bao; 2004 Jun; 56(3):335-40. PubMed ID: 15224146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosmarinic acid antagonized 1-methyl-4-phenylpyridinium (MPP+)-induced neurotoxicity in MES23.5 dopaminergic cells.
    Du T; Li L; Song N; Xie J; Jiang H
    Int J Toxicol; 2010 Dec; 29(6):625-33. PubMed ID: 20966113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnesium exerts both preventive and ameliorating effects in an in vitro rat Parkinson disease model involving 1-methyl-4-phenylpyridinium (MPP+) toxicity in dopaminergic neurons.
    Hashimoto T; Nishi K; Nagasao J; Tsuji S; Oyanagi K
    Brain Res; 2008 Mar; 1197():143-51. PubMed ID: 18242592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vasorelaxing role of vasonatrin peptide in human intramammary artery in vitro].
    Yu J; Zhu MZ; Wei GZ; Chen BY; Lu SY; Kang YF; Guo HT; Ma H; Dong MQ
    Sheng Li Xue Bao; 2003 Apr; 55(2):187-90. PubMed ID: 12715109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum.
    Xu G; Xiong Z; Yong Y; Wang Z; Ke Z; Xia Z; Hu Y
    Neuroscience; 2010 Apr; 167(1):174-84. PubMed ID: 20123001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of Gastrodia elata Blume on MPP+-induced cytotoxicity in human dopaminergic SH-SY5Y cells.
    An H; Kim IS; Koppula S; Kim BW; Park PJ; Lim BO; Choi WS; Lee KH; Choi DK
    J Ethnopharmacol; 2010 Jul; 130(2):290-8. PubMed ID: 20470875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats.
    Pain S; Barrier L; Deguil J; Milin S; Piriou A; Fauconneau B; Page G
    Toxicology; 2008 Jan; 243(1-2):124-37. PubMed ID: 18037221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS; Brown EM; Miller MS; Carswell S
    J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.